cdc7-in-7

Cdc7-IN-7 (compound I-E) 是一种有效的 Cdc7 激酶抑制剂。

Cdc7-IN-7c (Cdc7 inhibitor-7c) 具有抗肿瘤活性，对肝癌，肺癌，肾癌，脑癌，宫颈癌有抑制作用。

XL413 是一种口服生物可利用的细胞分裂周期 7 同源物 (CDC7) 激酶抑制剂，具有潜在的抗肿瘤活性，IC50值为 3.4 nM。它对 pMCM 的 EC50值为 118 nM，对 CK2 和 PIM1 的 IC50值分别为 215 和 42 nM。

Cdc7-IN-1 is a highly selective and ATP competitive inhibitor of Cdc7 kinase (IC50: 0.6 nM at 1 mM ATP). It potently inhibits Cdc7 activity in cancer cells and effectively induces cell death.

Cdc7-IN-3 is a potent inhibitor of Cdc7 kinase.

Cdc7-IN-4 is a potent inhibitor of Cdc7 kinase.

Cdc7-IN-5 是一种有效的 Cdc7 激酶抑制剂。Cdc7 是一种丝氨酸苏氨酸蛋白激酶酶，在细胞周期中对 DNA 复制的启动至关重要。